• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number CVD0091
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Hematoma (1884); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 08/12/2019
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2019, a 20mm amplatzer septal occluder was implanted.The device was used to close a defect ballooned sized to 20.2mm by fluoroscopy and 18mm by echo with a 25mm pts sizing balloon.The site initially attempted closure with a 30mm gore cardioform occluder, but the device did not sit well and was exchanged for the 20mm septal occluder.On (b)(6) 2019, the patient presented at the emergency room with chest pain and a pericardial effusion was verified by echo.The patient was taken into surgery for device removal and patch repair via an open sternotomy.The surgeon identified a perforation in the roof of the left atrium in the area of the superior rim and a hematoma in the pericardial space.The surgery was completed without further complication.On (b)(6) 2019, the patient was discharged from the hospital.
 
Manufacturer Narrative
An event of pericardial effusion, device removal, a perforation in the area of the superior rim, and a hematoma in the pericardial space was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9081639
MDR Text Key162951611
Report Number2135147-2019-00269
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Model NumberCVD0091
Device Lot Number5175835
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/20/2019
Initial Date FDA Received09/18/2019
Supplement Dates Manufacturer Received08/20/2019
Supplement Dates FDA Received11/07/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/29/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age18 YR
Patient Weight62
-
-